Stockholders' Deficiency (Details 4) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Number of warrants, outstanding
Outstanding, beginning of period (in shares)	2,183,899	2,165,925
Granted	935,500	416,000
Exercised		(231,357)
Forfeited	(576,249)	(166,669)
Outstanding, end of period (in shares)	2,543,150	2,183,899
Exercisable, December 31, 2013	1,235,650
Weighted average exercise price
Outstanding, beginning of period (in dollars per share)	$ 3.42	$ 2.89
Granted	$ 0.91	$ 5.39
Exercised		$ 1.62
Forfeited	$ 3.96	$ 4.03
Outstanding, end of period (in dollars per share)	$ 2.37	$ 3.42
Exercisable, December 31, 2013	$ 2.73
Weighted Average Remaining Life In Years
Weighted Average Remaining Life (in years) Outstanding	6 years
Weighted Average Remaining Life (in years) Exercisable	3 years 9 months 18 days
Aggregate Intrinsic Value
Aggregate Intrinsic Value Outstanding
Aggregate Intrinsic Value Exercisable
Warrant [Member]
Number of warrants, outstanding
Outstanding, beginning of period (in shares)	592,846	2,916,590
Granted	14,255,023	30,000
Exercised	(12,505,023)	(2,353,744)
Forfeited
Outstanding, end of period (in shares)	2,342,846	592,846
Exercisable, December 31, 2013	2,072,846
Weighted average exercise price
Outstanding, beginning of period (in dollars per share)	$ 3.01	$ 2.53
Granted	$ 0.28	$ 2.9
Exercised	$ 0.28	$ 1.6
Forfeited
Outstanding, end of period (in dollars per share)	$ 0.94	$ 3.01
Exercisable, December 31, 2013	$ 0.66
Weighted Average Remaining Life In Years
Weighted Average Remaining Life (in years) Outstanding	3 years 10 months 24 days
Weighted Average Remaining Life (in years) Exercisable	4 years
Aggregate Intrinsic Value
Aggregate Intrinsic Value Outstanding	37,918
Aggregate Intrinsic Value Exercisable	$ 37,918